{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:54:42Z","timestamp":1792122882645,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-024-04741-5","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:02:39Z","timestamp":1729242159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review"],"prefix":"10.1007","volume":"39","author":[{"given":"Dengzhuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"1","key":"4741_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 7(1):69\u201376","journal-title":"Lancet Oncol"},{"issue":"1","key":"4741_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3322\/caac.21749","volume":"73","author":"JM Foster","year":"2023","unstructured":"Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR (2023) The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J Clin 73(1):49\u201371. https:\/\/doi.org\/10.3322\/caac.21749","journal-title":"CA Cancer J Clin"},{"key":"4741_CR3","doi-asserted-by":"publisher","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009 Feb 10;27(5):681e5. https:\/\/doi.org\/10.1200\/JCO.2008.19.7160.","DOI":"10.1200\/JCO.2008.19.7160"},{"key":"4741_CR4","doi-asserted-by":"publisher","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010 Sep;17(9):2370e7. https:\/\/doi.org\/10.1245\/s10434-010-1039-7.","DOI":"10.1245\/s10434-010-1039-7"},{"key":"4741_CR5","doi-asserted-by":"publisher","unstructured":"van Driel WJ, Koole SN, Sonke GS, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018 Jan;378(3):230e40. https:\/\/doi.org\/10.1056\/NEJMoa1708618.","DOI":"10.1056\/NEJMoa1708618"},{"key":"4741_CR6","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608\u20135618. https:\/\/doi.org\/10.1002\/cncr.25356","journal-title":"Cancer"},{"key":"4741_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K et al (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis 17:772\u2013778. https:\/\/doi.org\/10.1111\/codi.12975","journal-title":"Colorectal Dis"},{"issue":"2","key":"4741_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","volume":"50","author":"D Elias","year":"2014","unstructured":"Elias D, Go\u00e9r\u00e9 D, Dumont F et al (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 50(2):332\u2013340. https:\/\/doi.org\/10.1016\/j.ejca.2013.09.024","journal-title":"Eur J Cancer"},{"issue":"5","key":"4741_CR9","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA et al (2015) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 22(5):1686\u20131693. https:\/\/doi.org\/10.1245\/s10434-014-3978-x","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"4741_CR10","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.3390\/jcm12206443","volume":"12","author":"BJ Sun","year":"2023","unstructured":"Sun BJ, Daniel SK, Lee B (2023) The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer. J Clin Med 12(20):6443. https:\/\/doi.org\/10.3390\/jcm12206443","journal-title":"J Clin Med"},{"issue":"1","key":"4741_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/SLA.0b013e3181b5ae43","volume":"251","author":"TC Chua","year":"2010","unstructured":"Chua TC, Saxena A, Schellekens JF, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL (2010) Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 251(1):101\u2013106. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b5ae43. (PMID: 19838105)","journal-title":"Ann Surg"},{"issue":"2","key":"4741_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH (2007) Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2013a prospective study of 70 consecutive cases. Ann Surg Oncol 14(2):515\u2013525. https:\/\/doi.org\/10.1245\/s10434-006-9187-5","journal-title":"Ann Surg Oncol"},{"key":"4741_CR13","doi-asserted-by":"publisher","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, de Forges H, Paineau J, Glehen O; UNICANCER-GI Group and BIG Renape Group. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Feb;22(2):256\u2013266. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4","DOI":"10.1016\/S1470-2045(20)30599-4"},{"issue":"1","key":"4741_CR14","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847IF","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, Bartlett D, Smith L (2019) Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures. JAMA Netw Open 2(1):e186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847IF","journal-title":"JAMA Netw Open"},{"issue":"3","key":"4741_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1515\/pp-2022-0203","volume":"8","author":"A Kartik","year":"2023","unstructured":"Kartik A, M\u00fcller C, Acs M, Piso P, Starlinger P, Bachleitner-Hofmann T, Grotz TE (2023) Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Pleura Peritoneum 8(3):113\u2013121. https:\/\/doi.org\/10.1515\/pp-2022-0203","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"4741_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/jso.24746","volume":"116","author":"A Rottenstreich","year":"2017","unstructured":"Rottenstreich A, Kalish Y, Kleinstern G, Yaacov AB, Dux J, Nissan A (2017) Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 116(7):914\u2013920. https:\/\/doi.org\/10.1002\/jso.24746","journal-title":"J Surg Oncol"},{"key":"4741_CR17","doi-asserted-by":"publisher","unstructured":"Klos D, Ri\u0161ko J, Kriv\u00e1\u010dkov\u00e1 D, Love\u010dek M, Skalick\u00fd P, Neoral \u010c, Melichar B, Moheln\u00edkov\u00e1-Ducho\u0148ov\u00e1 B, Lemstrov\u00e1 R. Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study. Eur J Surg Oncol. 2020 Apr;46(4 Pt A):607\u2013612. https:\/\/doi.org\/10.1016\/j.ejso.2020.01.020","DOI":"10.1016\/j.ejso.2020.01.020"},{"key":"4741_CR18","doi-asserted-by":"publisher","unstructured":"Carias E, Ferreira H, Chuva T, Paiva A, Maximino J. Acute Kidney Injury After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Portuguese Population. World J Oncol. 2022 Dec;13(6):370\u2013378. https:\/\/doi.org\/10.14740\/wjon1540","DOI":"10.14740\/wjon1540"},{"issue":"2","key":"4741_CR19","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/ajco.13275","volume":"16","author":"EYT Wong","year":"2020","unstructured":"Wong EYT, Tan GHC, Kumar M, Teo MCC (2020) Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Asia Pac J Clin Oncol 16(2):e38\u2013e46. https:\/\/doi.org\/10.1111\/ajco.13275","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"4741_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.21037\/apm-20-2334","volume":"10","author":"J Zhao","year":"2021","unstructured":"Zhao J, Zhang Y, Yang X, Wang Z, Song Q, Gong P, Zhao S, Liu F, Zhang Z, Bai W, Li Y (2021) Risk factors of pleural effusion after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in late-stage and recurrent ovarian cancer. Ann Palliat Med 10(1):385\u2013391. https:\/\/doi.org\/10.21037\/apm-20-2334","journal-title":"Ann Palliat Med"},{"key":"4741_CR21","doi-asserted-by":"publisher","unstructured":"Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2017 Apr;24(4):890\u2013897. https:\/\/doi.org\/10.1245\/s10434-016-5738-6","DOI":"10.1245\/s10434-016-5738-6"},{"key":"4741_CR22","doi-asserted-by":"publisher","unstructured":"Li XB, Ma R, Ji ZH, Lin YL, Zhang J, Yang ZR, Chen LF, Yan FC, Li Y. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. Eur J Surg Oncol. 2020 Apr;46(4 Pt A):600\u2013606. https:\/\/doi.org\/10.1016\/j.ejso.2020.01.017","DOI":"10.1016\/j.ejso.2020.01.017"},{"issue":"12","key":"4741_CR23","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s00268-016-3635-6","volume":"40","author":"M Dazza","year":"2016","unstructured":"Dazza M, Schwarz L, Coget J, Frebourg N, Wood G, Huet E, Bridoux V, Veber B, Tuech JJ (2016) Does Intraoperative Systematic Bacterial Sampling During Complete Cytoreductive Surgery (CRS) with Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) Influence Postoperative Treatment? A New Predictive Factor for Postoperative Abdominal Infectious Complications. World J Surg 40(12):3035\u20133043. https:\/\/doi.org\/10.1007\/s00268-016-3635-6","journal-title":"World J Surg"},{"issue":"2019","key":"4741_CR24","doi-asserted-by":"publisher","first-page":"2824073","DOI":"10.1155\/2019\/2824073","volume":"2","author":"M Cardi","year":"2019","unstructured":"Cardi M, Sibio S, Di Marzo F, Lefoche F, d\u2019Agostino C, Fonsi GB, La Torre G, Carbonari L, Sammartino P (2019) Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center. Gastroenterol Res Pract 2(2019):2824073. https:\/\/doi.org\/10.1155\/2019\/2824073","journal-title":"Gastroenterol Res Pract"},{"key":"4741_CR25","doi-asserted-by":"publisher","unstructured":"Arslan NC, Sokmen S, Avkan-Oguz V, Obuz F, Canda AE, Terzi C, Fuzun M. Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy. Surg Infect (Larchmt). 2017 Feb\/Mar;18(2):157\u2013163. https:\/\/doi.org\/10.1089\/sur.2016.102","DOI":"10.1089\/sur.2016.102"},{"issue":"1","key":"4741_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1186\/s12885-023-11404-1","volume":"23","author":"R Yang","year":"2023","unstructured":"Yang R, Zhao X, Fu YB, Lin YL, Ma R, Su YD, Wu HL, Liang XL, Li Y (2023) Etiological analysis of infection after CRS + HIPEC in patients with PMP. BMC Cancer 23(1):903. https:\/\/doi.org\/10.1186\/s12885-023-11404-1","journal-title":"BMC Cancer"},{"issue":"35","key":"4741_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.amsu.2018.09.036","volume":"26","author":"SA Naffouje","year":"2018","unstructured":"Naffouje SA, Tulla KA, Chorley R, Armstrong N, Salti GI (2018) Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg (Lond) 26(35):163\u2013168. https:\/\/doi.org\/10.1016\/j.amsu.2018.09.036","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"4741_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.14744\/tjtes.2023.52358","volume":"29","author":"T Bisgin","year":"2023","unstructured":"Bisgin T, S\u00f6kmen S, Arslan NC, Ozkardesler S, Barlik OF (2023) The risk factors for gastrointestinal anastomotic leak after cytoreduction with hyperthermic intraperitoneal chemotherapy. Ulus Travma Acil Cerrahi Derg 29(3):370\u2013378. https:\/\/doi.org\/10.14744\/tjtes.2023.52358","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"4741_CR29","doi-asserted-by":"publisher","unstructured":"Mitani Y, Arai Y, Tomohiro Mitani, Gohda Y, Yano H, Kondo I, Sakamoto E, Katagiri D, Hinoshita F. Association of intraoperative gross hematuria with acute kidney injury after cytoreductive surgery. Pleura Peritoneum. 2022 Feb 18;7(1):19\u201326. https:\/\/doi.org\/10.1515\/pp-2021-0145","DOI":"10.1515\/pp-2021-0145"},{"issue":"Suppl 3","key":"4741_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1245\/s10434-019-07739-4","volume":"26","author":"D Solomon","year":"2019","unstructured":"Solomon D, Bekhor E, Leigh N, Maniar YM, Totin L, Hofstedt M, Aycart SN, Carr J, Ballentine S, Magge DR, Golas BJ, Pai RK, Polydorides AD, Bartlett DL, Labow DM, Choudry HA, Sarpel U (2019) Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience. Ann Surg Oncol 26(Suppl 3):890. https:\/\/doi.org\/10.1245\/s10434-019-07739-4. (Erratumfor:AnnSurgOncol.2019Aug5)","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4741_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.23736\/S0026-4733.18.07649-6","volume":"74","author":"M Robella","year":"2019","unstructured":"Robella M, Vaira M, Cinquegrana A, De Simone M (2019) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes. Minerva Chir 74(3):195\u2013202. https:\/\/doi.org\/10.23736\/S0026-4733.18.07649-6","journal-title":"Minerva Chir"},{"key":"4741_CR32","doi-asserted-by":"publisher","unstructured":"Govaerts K, Lurvink RJ, De Hingh IHJT, Van der Speeten K, Villeneuve L, Kusamura S, Kepenekian V, Deraco M, Glehen O, Moran BJ; PSOGI. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021 Jan;47(1):11\u201335. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012","DOI":"10.1016\/j.ejso.2020.02.012"},{"issue":"2","key":"4741_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"4741_CR34","doi-asserted-by":"publisher","unstructured":"Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec;27(13):4980\u20134995. https:\/\/doi.org\/10.1245\/s10434-020-08843-6","DOI":"10.1245\/s10434-020-08843-6"},{"issue":"2","key":"4741_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1245\/s10434-018-07092-y","volume":"26","author":"RJ Hendrix","year":"2019","unstructured":"Hendrix RJ, Damle A, Williams C, Harris A, Spanakis S, Lambert DH, Lambert LA (2019) Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion. Ann Surg Oncol 26(2):490\u2013496. https:\/\/doi.org\/10.1245\/s10434-018-07092-y","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4741_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1515\/pp-2022-0001","volume":"7","author":"R Gupta","year":"2022","unstructured":"Gupta R, Gupta N, Sirohiya P, Pandit A, Ratre BK, Vig S, Bhan S, Singh R, Kumar B, Bhopale S, Mishra S, Garg R, Bharati SJ, Kumar V, Deo S, Bhatnagar S (2022) Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre. Pleura Peritoneum 7(3):127\u2013134. https:\/\/doi.org\/10.1515\/pp-2022-0001","journal-title":"Pleura Peritoneum"},{"issue":"6","key":"4741_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249(6):900\u2013907. https:\/\/doi.org\/10.1097\/SLA.0b013e3181a45d86","journal-title":"Ann Surg"},{"issue":"3","key":"4741_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH (2016) Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis. Ann Surg Oncol 23(3):833\u2013841. https:\/\/doi.org\/10.1245\/s10434-015-4892-6","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"4741_CR39","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/JS9.0000000000000418","volume":"109","author":"S Dai","year":"2023","unstructured":"Dai S, Peng Y, Wang G, Yin L, Yan H, Xi C, Guo F, Chen J, Tu M, Lu Z, Wei J, Gao W, Jiang K, Wu J, Miao Y (2023) Risk factors of delayed gastric emptying in patients after pancreaticoduodenectomy: a comprehensive systematic review and meta-analysis. Int J Surg 109(7):2096\u20132119. https:\/\/doi.org\/10.1097\/JS9.0000000000000418","journal-title":"Int J Surg"},{"key":"4741_CR40","doi-asserted-by":"publisher","unstructured":"Filis P, Mauri D, Markozannes G, Tolia M, Filis N, Tsilidis K. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. ESMO Open. 2022 Oct;7(5):100586. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100586","DOI":"10.1016\/j.esmoop.2022.100586"},{"key":"4741_CR41","doi-asserted-by":"publisher","unstructured":"Lin T, Chen X, Xu Z, Hu Y, Liu H, Yu J, Li G. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: a Phase II study of CLASS-05 trial. Gastroenterol Rep (Oxf). 2024 12:goae001. https:\/\/doi.org\/10.1093\/gastro\/goae001","DOI":"10.1093\/gastro\/goae001"},{"issue":"14","key":"4741_CR42","doi-asserted-by":"publisher","first-page":"1094834","DOI":"10.3389\/fphar.2023.1094834","volume":"9","author":"C Jian","year":"2023","unstructured":"Jian C, Mou H, Zhang Y, Fan Q, Ou Y (2023) Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials. Front Pharmacol 9(14):1094834. https:\/\/doi.org\/10.3389\/fphar.2023.1094834","journal-title":"Front Pharmacol"},{"issue":"15","key":"4741_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12871-015-0079-8","volume":"4","author":"VE Ortiz","year":"2015","unstructured":"Ortiz VE, Kwo J (2015) Obesity: physiologic changes and implications for preoperative management. BMC Anesthesiol 4(15):97. https:\/\/doi.org\/10.1186\/s12871-015-0079-8","journal-title":"BMC Anesthesiol"},{"issue":"12","key":"4741_CR44","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.3390\/cancers14122853.PMID:35740519;PMCID:PMC9221457","volume":"14","author":"DC Freudenberger","year":"2022","unstructured":"Freudenberger DC, Vudatha V, Riner AN, Herremans KM, Fernandez LJ, Trevino JG (2022) A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers (Basel) 14(12):2853. https:\/\/doi.org\/10.3390\/cancers14122853.PMID:35740519;PMCID:PMC9221457","journal-title":"Cancers (Basel)"},{"issue":"8","key":"4741_CR45","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1245\/s10434-008-9990-2","volume":"15","author":"JT Mullen","year":"2008","unstructured":"Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, Moorman DW (2008) Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 15(8):2164\u20132172. https:\/\/doi.org\/10.1245\/s10434-008-9990-2","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4741_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00007890-199002000-00032","volume":"49","author":"JL Holley","year":"1990","unstructured":"Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakala TR, Starzl TE (1990) Obesity as a risk factor following cadaveric renal transplantation. Transplantation 49(2):387\u2013389. https:\/\/doi.org\/10.1097\/00007890-199002000-00032","journal-title":"Transplantation"},{"issue":"4 Pt 1","key":"4741_CR47","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.ju.0000138785.48347.aa","volume":"172","author":"CT Lee","year":"2004","unstructured":"Lee CT, Dunn RL, Chen BT, Joshi DP, Sheffield J, Montie JE (2004) Impact of body mass index on radical cystectomy. J Urol 172(4 Pt 1):1281\u20131285. https:\/\/doi.org\/10.1097\/01.ju.0000138785.48347.aa","journal-title":"J Urol"},{"issue":"2","key":"4741_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11605-007-0421-7","volume":"12","author":"MG House","year":"2008","unstructured":"House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12(2):270\u2013278. https:\/\/doi.org\/10.1007\/s11605-007-0421-7","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"4741_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3171\/spi.2007.6.4.1","volume":"6","author":"N Patel","year":"2007","unstructured":"Patel N, Bagan B, Vadera S, Maltenfort MG, Deutsch H, Vaccaro AR, Harrop J, Sharan A, Ratliff JK (2007) Obesity and spine surgery: relation to perioperative complications. J Neurosurg Spine 6(4):291\u2013297. https:\/\/doi.org\/10.3171\/spi.2007.6.4.1","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"4741_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s0002-9610(00)00337-8","volume":"179","author":"S Benoist","year":"2000","unstructured":"Benoist S, Panis Y, Alves A, Valleur P (2000) Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 179(4):275\u2013281. https:\/\/doi.org\/10.1016\/s0002-9610(00)00337-8","journal-title":"Am J Surg"},{"issue":"2","key":"4741_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/SLA.0b013e31823dcbf7","volume":"255","author":"T Makino","year":"2012","unstructured":"Makino T, Shukla PJ, Rubino F, Milsom JW (2012) The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann Surg 255(2):228\u2013236. https:\/\/doi.org\/10.1097\/SLA.0b013e31823dcbf7","journal-title":"Ann Surg"},{"key":"4741_CR52","doi-asserted-by":"publisher","unstructured":"Veterans Affairs Total Parenteral Nutrition Cooperative Study Group 1991 Aug 22 Perioperative total parenteral nutrition in surgical patients N Engl J Med 325 8 525 532 https:\/\/doi.org\/10.1056\/NEJM199108223250801","DOI":"10.1056\/NEJM199108223250801"},{"issue":"3","key":"4741_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/bjs.5626","volume":"94","author":"S Palma","year":"2007","unstructured":"Palma S, Cosano A, Mariscal M, Mart\u00ednez-Gallego G, Medina-Cuadros M, Delgado-Rodr\u00edguez M (2007) Cholesterol and serum albumin as risk factors for death in patients undergoing general surgery. Br J Surg 94(3):369\u2013375. https:\/\/doi.org\/10.1002\/bjs.5626","journal-title":"Br J Surg"},{"key":"4741_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"issue":"4","key":"4741_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jso.21068","volume":"98","author":"AG Portilla","year":"2008","unstructured":"Portilla AG, Shigeki K, Dario B, Marcello D (2008) The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 98(4):228\u2013231. https:\/\/doi.org\/10.1002\/jso.21068","journal-title":"J Surg Oncol"},{"key":"4741_CR56","doi-asserted-by":"publisher","unstructured":"Llueca A, Escrig J; MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery). Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. Eur J Surg Oncol. 2018 Jan;44(1):163\u2013169. https:\/\/doi.org\/10.1016\/j.ejso.2017.11.003","DOI":"10.1016\/j.ejso.2017.11.003"},{"issue":"8","key":"4741_CR57","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","volume":"125","author":"G Avesani","year":"2020","unstructured":"Avesani G, Arshad M, Lu H, Fotopoulou C, Cannone F, Melotti R, Aboagye E, Rockall A (2020) Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol Med 125(8):770\u2013776. https:\/\/doi.org\/10.1007\/s11547-020-01170-6","journal-title":"Radiol Med"},{"issue":"3","key":"4741_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","volume":"48","author":"LCK Wong","year":"2022","unstructured":"Wong LCK, Li Z, Fan Q, Tan JW, Tan QX, Wong JSM, Ong CJ, Chia CS (2022) Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis-A systematic review and meta-analysis. Eur J Surg Oncol 48(3):640\u2013648. https:\/\/doi.org\/10.1016\/j.ejso.2021.10.013","journal-title":"Eur J Surg Oncol"},{"key":"4741_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","volume":"142","author":"DD Wisselink","year":"2019","unstructured":"Wisselink DD, Braakhuis LLF, Gallo G, van Grevenstein WMU, van Dieren S, Kok NFM, de Reuver PR, Tanis PJ, de Hingh IHJT (2019) Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer. Crit Rev Oncol Hematol 142:119\u2013129. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.06.014","journal-title":"Crit Rev Oncol Hematol"},{"key":"4741_CR60","doi-asserted-by":"publisher","first-page":"102080","DOI":"10.1016\/j.suronc.2024.102080","volume":"54","author":"J Herzberg","year":"2024","unstructured":"Herzberg J, Acs M, Guraya SY, Schlitt HJ, Honarpisheh H, Strate T, Piso P (2024) Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study. Surg Oncol 54:102080. https:\/\/doi.org\/10.1016\/j.suronc.2024.102080","journal-title":"Surg Oncol"},{"issue":"1","key":"4741_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12672-024-00968-4","volume":"15","author":"G Hotza","year":"2024","unstructured":"Hotza G, Karageorgos M, Pastourmatzi V, Baniowda N, Kyziridis D, Kalakonas A, Chavouzis N, Hotza I, Tentes AA (2024) Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Discov Oncol 15(1):106. https:\/\/doi.org\/10.1007\/s12672-024-00968-4","journal-title":"Discov Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:03:54Z","timestamp":1736363034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4741"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04741-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"10 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study does not require approval since it is a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}